Leonardo Jaimes, MD

All articles by Leonardo Jaimes, MD

• Obeticholic acid improves outcomes for PBC patients in clinical trial

  Treatment with obeticholic acid (OCA) improved outcomes for primary biliary cholangitis (PBC) patients in a recent clinical trial.

• Obstacles in PBC care lead to delayed diagnosis and treatment

  A recent study found that some PBC patients face more barriers to care, leading to a delay in diagnosis and treatment.

• Mirum’s potential PBC therapy shows positive preliminary results

  A phase 2b clinical trial has shown positive preliminary results for volixibat intended for the treatment of PBC.

• FDA approves Ipsen’s Elafibranor for the treatment of PBC

  Ipsen’s Iqirvo (elafibranor) is the first new medicine approved in nearly a decade for the treatment of the PBC, according to a recent press release.

• Ipsen launches new trial studying potential PBC treatment

  Ipsen is recruiting participants for a trial assessing the safety and efficacy of elafibranor in primary biliary cholangitis (PBC).

• New gene potentially linked to PBC in recent study

  A recent study showed the PTPN2 gene may be associated with increased risk for primary biliary cholangitis (PBC).

• Phase 3 trial shows elafibranor safe and effective in PBC

  The drug elafibranor appears to be effective and safe for the treatment of primary biliary cholangitis (PBC) in a phase 3 trial.